Sangamo Therapeutics
SGMO
#10416
Rank
C$43.21 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-84.35%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of March 2026 : C$27.25 Million

According to Sangamo Therapeutics 's latest financial reports the company's total debt is C$27.25 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$36.69 M-16.34%
2024-12-31C$43.86 M-13.21%
2023-12-31C$50.53 M-13.6%
2022-12-31C$58.49 M-4.54%
2021-12-31C$61.27 M14.19%
2020-12-31C$53.66 M-7.47%
2019-12-31C$57.99 M53.76%
2018-12-31C$37.71 M21.27%
2017-12-31C$31.1 M486.66%
2016-12-31C$5.3 M
2015-12-31N/A
2001-12-31C$0.45 M
1999-12-31C$0.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$77.51 B 284,335.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$80.81 B 296,418.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$9.25 B 33,843.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$27.67 B 101,436.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$31.26 B 114,601.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$69.24 B 253,970.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.79 B 6,485.25%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.02 B 7,346.72%๐Ÿ‡บ๐Ÿ‡ธ USA